The Owlet Sock 3 measures your baby’s heart rate and blood oxygen level using the same light-based sensor technology found in hospital pulse oximeters, but it is not a medical device and was never FDA-cleared in its original form. Its successor, the Owlet Dream Sock, uses the same core sensor (called the OSS 3.0) and earned FDA Class II clearance as an over-the-counter infant pulse oximeter. That clearance is the closest thing to an independent accuracy stamp the hardware has received.
Understanding what that means, and where the gaps are, matters if you’re deciding whether to trust the numbers on your phone at 2 a.m.
The FDA Story Behind the Sock 3
Owlet originally sold the Smart Sock 3 as a “wellness” product, deliberately avoiding the FDA clearance process. In 2021, the FDA issued a warning letter stating the device was functioning as a medical device without authorization, and Owlet pulled it from shelves. The company then submitted the same sensor technology for formal review. In 2023, the FDA granted De Novo Class II clearance to the Owlet Dream Sock, classifying it under the regulatory category for infant pulse rate and oxygen saturation monitors intended for over-the-counter home use.
Class II clearance means the FDA reviewed performance data and determined the device met safety and effectiveness standards for its intended use. It does not mean it performs identically to a hospital-grade monitor. The distinction matters: hospital pulse oximeters are held to tighter accuracy tolerances and are designed for continuous clinical monitoring, while the Dream Sock is cleared for parents to use at home on healthy infants.
How the Sensor Works
The sock uses photoplethysmography, the same principle behind the pulse oximeter a nurse clips to your finger. A small sensor on the bottom of the sock shines light through your baby’s foot and measures how much light is absorbed by the blood. Because oxygenated and deoxygenated blood absorb light differently, the sensor can estimate oxygen saturation (SpO2) and detect pulse rate from the rhythmic changes in blood flow.
Owlet recommends alternating the sock between feet every eight hours and after each recharge. The sensor is cleared for infants between 1 and 18 months old, weighing 6 to 30 pounds. Outside that range, accuracy has not been validated through the FDA process. A clinical trial registered on ClinicalTrials.gov is currently evaluating the OSS 3.0 sensor’s accuracy in smaller newborns (down to about 3.3 pounds) in a hospital setting, but results have not yet been published.
What We Know About Real-World Accuracy
Here is the honest picture: there is limited published, peer-reviewed data specifically quantifying the Sock 3’s accuracy against a hospital reference monitor in controlled conditions. The FDA clearance for the Dream Sock confirms the sensor met the agency’s performance benchmarks, but those internal test results are not fully detailed in the public decision summary. No independent study has yet published the kind of head-to-head comparison (with precise error margins like mean absolute deviation or root mean square error) that would let you say “it’s accurate to within X percent.”
What we do know from the broader pulse oximetry literature is that consumer-grade devices reading from the foot tend to be less precise than clinical monitors reading from the hand or earlobe. Foot placement introduces more variability because the tissue is thicker and blood flow can be affected by temperature, sock fit, and how much the baby moves. These factors don’t make the readings useless, but they do mean any single reading could be off by more than you’d see in a hospital.
Common Sources of Inaccurate Readings
Several practical factors influence how reliable the sock’s numbers are on any given night:
- Movement: When your baby kicks, rolls, or flexes their foot, the sensor can lose consistent contact with the skin. This creates what engineers call motion artifact, essentially noise in the signal that the software has to filter out. Heavy movement periods often trigger false notifications or temporarily unreliable readings.
- Fit: A sock that’s too loose lets ambient light leak in and disrupts the sensor. One that’s too tight can restrict blood flow to the foot, which paradoxically makes the oxygen reading less accurate. Getting the right sock size for your baby’s weight range matters more than most parents realize.
- Skin temperature: Cold feet have reduced blood flow, which weakens the signal the sensor depends on. If your baby’s nursery runs cool or their feet tend to be cold, readings may be less stable.
- Skin pigmentation: Pulse oximeters across all brands have documented accuracy differences across skin tones, with a tendency to slightly overestimate oxygen levels in people with darker skin. This is a known limitation of the underlying light-based technology, not specific to Owlet.
What the Sock Is Good At
The sock is reasonably good at detecting trends and significant changes. If your baby’s oxygen saturation drops substantially or their heart rate spikes well outside normal range, the device will likely catch it and send an alert. For the vast majority of healthy infants, this is the scenario parents care about: they want to know if something is clearly wrong, not whether SpO2 is 97% versus 98%.
A large early usage study of over 47,000 Owlet users (conducted on an earlier version of the hardware) showed that parents found the notifications actionable and that the device did flag events that, in some cases, led families to seek medical attention. That study did not, however, rigorously quantify accuracy against a gold-standard reference.
What the Sock Cannot Do
The Owlet Sock 3 and Dream Sock are not medical monitors and should not be used to diagnose or manage any condition. They cannot detect SIDS, despite what some parents hope. SIDS involves the sudden cessation of breathing, and while a pulse oximeter might eventually detect the resulting drop in oxygen, there is no evidence that consumer sock monitors reduce SIDS risk or improve outcomes. The American Academy of Pediatrics does not recommend home pulse oximetry monitors for healthy infants as a strategy to prevent SIDS.
The device is also not appropriate for infants with known heart or lung conditions. Babies who need reliable continuous monitoring belong on hospital-grade equipment prescribed and calibrated by their medical team. The Owlet’s cleared use case is narrow: overnight peace of mind for parents of healthy babies within the specified age and weight range.
How It Compares to Hospital Monitors
Hospital pulse oximeters, like those made by Masimo or Nellcor, are typically accurate to within 2 to 3 percentage points of actual blood oxygen levels across a wide range of conditions. They use carefully calibrated sensors, are placed on fingertips or earlobes where blood flow is strong, and are monitored by trained staff who can reposition them when readings look off.
The Owlet reads from the foot of a moving infant in an uncontrolled home environment with no clinical oversight. Even if the sensor hardware is comparable in quality, the conditions of use introduce more variability. Think of it this way: the same thermometer will give you a more precise reading if you hold it still under your tongue for 60 seconds versus waving it near your forehead while walking. The Owlet’s challenge is similar. The sensor is decent, but the conditions it operates in are inherently messier than a hospital.
For healthy babies with normal oxygen levels (typically 95% and above), this margin of error rarely matters in a practical sense. Where it becomes more concerning is at the lower end: if a baby’s true oxygen saturation is hovering around 90%, the difference between a reading of 88% (which would trigger an alert) and 93% (which would not) is clinically significant and exactly the range where consumer-grade accuracy limitations matter most.